Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies.Maryam Asadi, Nasrollah Erfani, Vahid Razban et al.|PubMed|2023Cited by 3